Re-expression of VHL in ccRCC cell lines results in degradation of HIF1α and HIF2α, elevation of CPT1A message and protein, and inhibition of the formation of lipid droplets. This evidence concerns the gene CPT1A and nonpapillary renal cell carcinoma.